Laserfiche WebLink
specimen within three hours, the DER, in consultation with the MRO, will direct the employee to <br />obtain a medical evaluation within five days to determine if there is an acceptable medical reason for <br />not being able to provide a specimen. If it is determined that there Is no acceptable physiological or <br />pre=existing psychological reason for not providing a urine specimen, it will be considered a refusal to <br />test.. <br />Directly observed collections . If a direct observation collection is required of the employee, the <br />Company will ensure that the DOTrequirements (i.e., direct observation by same -sax collector, <br />observation of body-to-bodle urination, and use of full turn -around observation) procedures are <br />followed. <br />4. PHMSA Inspection Protocol for Specimen Collection Sites <br />Compliance. PHMSA"s Substance Abuse Program: Comprehensive Audit and Inspection Protocol <br />Form, Combined Anti -Drug and Alcohol Misuse Prevention Programs, Form No.: 3.1.11, dated <br />January 29, 2010, provides a separate inspection protocol for Specimen Collection Sites, The <br />Company provides this protocol to correspond with the detail found in the PHMSA Inspection Form. <br />As previously stated, the Company will ensure that all DOT drug tests comply with Dart 40 <br />requirements. <br />Collection Personinell. The Company will ensure that only qualified collectors are used to conduct. <br />Company DOT tests. An immediate supervisor of an employee may be used In cases where there <br />are no qualified collectors available, and where their use is the only way to get the test conducted. <br />Collectors will maintain documentation to verify they meet training requirements and will make that <br />documentation available to the Company on request.31 If an error occurs causing a test to be <br />canceled and the error is directly attributed to the collector, the collector will undergo error - correction <br />training within 30 days of the date of notification of the error that led to the need for training. <br />32 <br />Collection Sites, (Forms and Supplies . The Company will use designated collection sites that meet <br />DOT requirements. 33 If the collection site uses a facility normally used for other purposes, the <br />collector will ensure that it meets DOT standards before continuing the Collection. 34 Access to <br />collection materials and specimens will be restricted, and the facility will be secured against access <br />during the procedure to ensure privacy to the employee and prevent distraction of the collector. <br />Limited -access signs will be posted as necessary. The collector will maintain personal control over <br />each specimen and CCF throughout the collection process and will prevent unauthorized personnel <br />from entering any part of the site in which urine specimens are collected or stored. 35 The current CCF <br />and a collection kit, that meets the requirements of Appendix A to Part 40, will be used for DOT <br />collections.3637 <br />Specimen Collections. Collectors will explain the basic collection procedure to the employee, <br />including showing the employee the instructions on the back of the CCF. 3e In most all collections, the <br />Company will provide the employee with a kit and CCF to carry to the collection site. In other <br />collections, collectors will provide the employee with an individually wrapped or sealed collection <br />container from the collection kit materlalO Precautions will be taken to ensure that unadulterated <br />specimens are obtained and correctly identified. Specimen integrity will be maintained by: bluing <br />agents being added in the toilet tank and all water sources secured; positive photo identification of <br />the employee for collection; notification of the DER if employee fails to arrive at the assigned time; <br />having the employee remove any unnecessary outer garments (purses or briefcases will remain with <br />outer garments); having employees wash and dry their hands; and, to the greatest extent possible, <br />the collector will keep an employee"'s collection container within view of both the collector and the <br />employee between the time the employee has urinated and the specimen is sealed. Any unusual <br />40 <br />behavior will be noted on the, CCF. <br />Following the collection, the specimen will be checked for sufficient volume (i.e., 45 mQ, acceptable <br />temperature, range ('i.e., between 90-100 degrees F), and shows no signs of tampering (e.g.,, color, <br />odor).41 Having problematic Issues with specimen volumeā€ž the collector will follow DOT"'s '"shy <br />bladder" procedures42; problems with temperature or tampering will result In the collector conducting <br />a second collection under direct observation (,see Section V.2, "Drug Tests That Require Direct <br />Observation Procedures"), 43 Direct observation procedures will be used for all collections where the <br />reason -for -test is either retm-to-duty or follow-up. Direct observation procedures will also be used <br />for collections when a specimen is provided and the temperature Is out of range, when the specimen <br />J. RANCK ELECTRIC, INC. <br />PHMSA DRUG/ALCOHOL PLAN! <br />NATIONAL COMPLIANCE MANAGEMENT SCRVICF, INC. (NCM&), - 2010 21 <br />